SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant downward pressure following an orbital anomaly during a Blue Origin launch that resulted in the loss of a satellite. While the company confirmed that insurance will cover the loss and that production of upcoming units remains on track, investors are expressing deep concern over potential timeline delays and the reliability of launch partners.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical Ltd. (PBM) is experiencing significant volatility and trading momentum driven by speculation surrounding a potential executive order aimed at fast-tracking psychedelic research for veteran mental health. Investors are heavily focused on the stock's low float and potential for a short squeeze, leading to heated discussions between bullish retail traders anticipating triple-digit price action and skeptical bears warning of a possible pump-and-dump scenario.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors monitor significant developments in the rare earths supply chain, including new commercial yttrium metal production and ongoing discussions regarding government funding and critical mineral trade agreements. The community is actively debating the company's valuation, potential technical breakout patterns, and the impact of geopolitical factors on domestic production capabilities.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is experiencing high volatility as investors react to the sudden resignation of its CEO and a strategic management shakeup, sparking debate over whether the leadership transition will accelerate or hinder the company's ability to secure a major data center tenant. While retail sentiment remains deeply divided between those viewing the price decline as a long-term buying opportunity and those concerned about the company's burn rate and lack of signed contracts, trading volume has surged amid speculation regarding potential partnerships and the company's critical role in AI energy infrastructure.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is drawing significant attention as investors react to reports of a custom AI chip collaboration with Google, marking a potential shift toward deeper hyperscaler integration. While some community members highlight the stock's recent rapid gains and extended valuation as a sign of caution, bulls remain focused on the company's expanding role in AI infrastructure and custom ASIC production.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is seeing significant investor attention driven by speculation surrounding upcoming clinical data readouts and potential partnership or buyout activity in the biotech sector. While bullish sentiment is fueled by anticipation of key oncology data and potential regulatory progress, the community remains divided, with some investors focusing on long-term pipeline potential while others express frustration over share price performance and past dilution.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to the release of positive preliminary data from the open-label arm of its Phase III FLAMINGO-01 trial, which showed a statistically significant reduction in breast cancer recurrence rates. The community is actively discussing the implications of this efficacy, noting the significant endorsement from the trial's global steering committee and high levels of insider investment, fueling optimism for upcoming data presentations at the AACR annual meeting.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Compass Pathways is trending as the community closely monitors a pivotal clinical data readout for its COMP360 psilocybin therapy, amid significant buzz around President Trump's recent executive order to fast-track psychedelic research. Investors are actively debating the company's valuation, its competitive positioning against other biotech players in the space, and the potential impact of new regulatory tailwinds on the sector's long-term commercialization prospects.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently trending as investors weigh strong steel shipment guidance for 2026 and optimism surrounding the company's integrated electrical steel capabilities against concerns regarding short-term earnings headwinds. The community is actively debating the potential for a strategic partnership with POSCO and the impact of the domestic transformer supply crunch on the company's long-term growth outlook.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

DRTS is gaining significant market attention as investors position themselves ahead of multiple clinical trial updates, specifically focused on pivotal readouts and oral presentations regarding pancreatic and skin cancer therapies. The community is increasingly bullish, highlighting a strong institutional presence and the company's clean balance sheet as key reasons for the stock's recent price strength despite broader market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nutex Health (NASDAQ:NUTX) Trading Down 6.4%  - Here's What Happened

Nutex Health (NASDAQ:NUTX) Trading Down 6.4% - Here's What Happened...

Insider Buying: Nutex Health (NASDAQ:NUTX) President Purchases 252 Shares of Stock

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) President Warren Hosseinion acquired 252 shares of the firm's stock in a transaction on Thursday, March 19th. The stock was bought at an average price of $94.07 per share, for a total transaction of $23,705.64. Following the completion of the...

Nutex Health (NASDAQ:NUTX) Director Purchases $14,034.00 in Stock

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) Director Frank Jaumot acquired 150 shares of the firm's stock in a transaction on Friday, March 20th. The stock was purchased at an average price of $93.56 per share, for a total transaction of $14,034.00. Following the completion of the...

Topline Capital Management LLC Buys 247,436 Shares of Nutex Health Inc. $NUTX

Topline Capital Management LLC grew its stake in Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 80.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex...

Pertento Partners LLP Buys New Position in Nutex Health Inc. $NUTX

Pertento Partners LLP purchased a new stake in Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Nutex Health (NASDAQ:NUTX) Shares Down 5.5% - Time to Sell?

Nutex Health (NASDAQ:NUTX) Trading Down 5.5% - Time to Sell...

Nutex Health (NASDAQ:NUTX) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen downgraded shares of Nutex Health from a "strong-buy" rating to a "hold" rating in a report on Saturday...

Nutex Health Q4 Earnings Call Highlights

Nutex Health (NASDAQ:NUTX) management highlighted sharp full-year revenue and earnings growth in 2025, improved cash generation, and continued progress navigating reimbursement under the Independent...

Nutex Health (NASDAQ:NUTX) Issues Quarterly Earnings Results

Nutex Health (NASDAQ:NUTX - Get Free Report) announced its earnings results on Thursday. The company reported $1.61 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of...

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

Current Price	$105.58
Prev Close	$101.76
Open	$105.75
Dividend Yield	0.00%
50-Day Moving Average	$100.72
Beta	1.50
Avg. Volume	223,612.17
PE Ratio	10.86

52-Week High	$193.07
52-Week Low	$77.21
Market Capitalization	$735.72M
EPS (Annual)	$10.48
Price to Book	2.27
Revenue Per Employee	$927,179.03

NUTX
Nutex Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NUTX News

NUTXNutex Health Inc